Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 198

    Gilead cell therapy Yescarta proves durable for some lymphoma patients

    Gilead cell therapy Yescarta proves durable for some lymphoma patients

    Farhat Nasim3 Dec 2018 9:00 AM IST
    SAN DIEGO: Nearly 40 per cent of lymphoma patients treated with a single infusion of Gilead Sciences Inc's Yescarta were still responding to the cell...
    Lupin launches Nystatin and Triamcinolone Acetonide in the US market

    Lupin launches Nystatin and Triamcinolone Acetonide in the US market

    Farhat Nasim3 Dec 2018 3:20 AM IST
    The company has launched the product after having received approval from the US Food and Drug Administration (USFDA) earlier, Lupin said in a...
    Regulations on Biotech sector must ease further: Biocon Chief

    Regulations on Biotech sector must ease further: Biocon Chief

    Farhat Nasim2 Dec 2018 12:55 PM IST
    Tax reform has had a minimal impact on the biotechnology sector because it is an export-oriented business, Shaw said. However, the sector is heavily...
    Launch of User Manual on SUGAM portal: CDSCO

    Launch of User Manual on SUGAM portal: CDSCO

    Medical Dialogues Bureau2 Dec 2018 12:00 PM IST
    New Delhi: Through a public notice released on 29.11.2018 Central Drugs Standard Control Organisation(CDSCO) has announced the launch of a User...
    FDA nods to Truxima-first biosimilar to Roche cancer drug Rituxan

    FDA nods to Truxima-first biosimilar to Roche cancer drug Rituxan

    Medical Dialogues Bureau2 Dec 2018 9:20 AM IST
    New Delhi: Celltrion Inc's Truxima on Wednesday became the first biosimilar to Roche Holding AG's $7-billion-per-year cancer drug Rituxan to be...
    Biotech company Moderna expects to raise up to around 36 crore in Initial Public Offering

    Biotech company Moderna expects to raise up to around 36 crore in Initial Public Offering

    Medical Dialogues Bureau2 Dec 2018 9:01 AM IST
    New Delhi: Biotech company Moderna Inc recently said it expects to raise up to $521.7 million(Rs 36,39,90,09,000) in its initial public offering,...
    Application for Bulk Vaccine to be filed mandatorily through SUGAM: CDSCO

    Application for Bulk Vaccine to be filed mandatorily through SUGAM: CDSCO

    Medical Dialogues Bureau1 Dec 2018 10:35 AM IST
    It is now decided that no physical application for Bulk Vaccine will be accepted and all applications should be necessarily filed through SUGAM...
    Neuland Laboratories announces successful plant inspection by USFDA, no observation

    Neuland Laboratories announces successful plant inspection by USFDA, no observation

    Farhat Nasim1 Dec 2018 9:55 AM IST
    New Delhi: Neuland Laboratories witnessed a surge in its share on Thursday after USFDA issued no observation to its manufacturing facility located at...
    Merck increases price of five drugs including Keytruda in November

    Merck increases price of five drugs including Keytruda in November

    Medical Dialogues Bureau1 Dec 2018 9:15 AM IST
    NEW YORK: Merck & Co Inc said on Wednesday it raised U.S. prices on five of its drugs earlier in November by between 1.5 per cent and 6 per cent,...
    Zydus Cadila gets USFDA nod to market generic Lansoprazole tablets

    Zydus Cadila gets USFDA nod to market generic Lansoprazole tablets

    Medical Dialogues Bureau1 Dec 2018 9:05 AM IST
    New Delhi: Drug firm Zydus Cadila has recently said it has received the final nod from the US health regulator to market generic Lansoprazole tablets...
    Unilever CEO retires , replaced by insider Jope

    Unilever CEO retires , replaced by insider Jope

    Medical Dialogues Bureau1 Dec 2018 9:00 AM IST
    LONDON: Unilever's Chief Executive Paul Polman will step down next month after 10 years in the job, leaving insider Alan Jope to step into his shoes...
    SEBI nod to Inventia Healthcare for Initial Public Offering

    SEBI nod to Inventia Healthcare for Initial Public Offering

    Medical Dialogues Bureau30 Nov 2018 10:00 AM IST
    New Delhi: Inventia Healthcare received markets regulator Security and Exchange Board of India(Sebi's) approval to float initial public...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok